1. | [Articles] Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study | Gonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, Martin Kerick, José Hernández-Rodríguez, Sarah L Mackie, Augusto Vaglio, Santos Castañeda, Roser Solans, Jaume Mestre-Torres, Nader Khalidi, Carol A Langford, Steven Ytterberg, Lorenzo Beretta, Marcello Govoni, Giacomo Emmi, Marco A Cimmino, Torsten Witte, Thomas Neumann, Julia Holle, Verena Schönau, Gregory Pugnet, Thomas Papo, Julien Haroche, Alfred Mahr, Luc Mouthon, Øyvind Molberg, Andreas P Diamantopoulos, Alexandre Voskuyl, Thomas Daikeler, Christoph T Berger, Eamonn S Molloy, Daniel Blockmans, Yannick van Sleen, Mark Iles, Louise Sorensen, Raashid Luqmani, Gary Reynolds, Marwan Bukhari, Shweta Bhagat, Norberto Ortego-Centeno, Elisabeth Brouwer, Peter Lamprecht, Sebastian Klapa, Carlo Salvarani, Peter A Merkel, María C Cid, Miguel A González-Gay, Ann W Morgan, Javier Martin, Ana Márquez, Spanish GCA Group, UK GCA Consortium, Vasculitis Clinical Research Consortium | |
2. | [Articles] Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial | Carl S Goodyear, Amit Patel, Eleanor Barnes, Michelle Willicombe, Stefan Siebert, Thushan I de Silva, John A Snowden, Sean H Lim, Sarah J Bowden, Lucinda Billingham, Alex Richter, Miles Carroll, Edward J Carr, Rupert Beale, Daniel Rea, Helen Parry, Sarah Pirrie, Zixiang Lim, Jack Satsangi, Susanna J Dunachie, Gordon Cook, Paul Miller, Neil Basu, Ashley Gilmour, Anne-Marie Hodgkins, Lili Evans, Ana Hughes, Stephanie Longet, Georgina Meacham, Kwee L Yong, Matthew J A'Hearne, Mickey B C Koh, Siobhan O Burns, Kim Orchard, Caron Paterson, Graham McIlroy, Sam M Murray, Tina Thomson, Stavros Dimitriadis, Lyndsey Goulston, Samantha Miller, Victoria Keillor, Maria Prendecki, David Thomas, Amanda Kirkham, Iain B McInnes, Pamela Kearns, OCTAVE-DUO investigators | |
3. | [Comment] Giant cell arteritis: when genomics drives precision medicine | Davide Martorana, Ingeborg M Bajema | |
4. | [Comment] Additional SARS-CoV-2 vaccine doses: a little is better than none | Alfred H J Kim | |
5. | [Viewpoint] Clinical assessment and management of lumbar spinal stenosis: clinical dilemmas and considerations for surgical referral | David B Anderson, David J Beard, Francois Rannou, David J Hunter, Pradeep Suri, Lingxiao Chen, James M Van Gelder | |
6. | [Review] Precision medicine in Sjögren's disease | Saviana Gandolfo, Michele Bombardieri, Jacques-Olivier Pers, Xavier Mariette, Francesco Ciccia | |
7. | [Articles] Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial | Jin Kyun Park, Miriam Kim, Ji In Jung, Ju Yeon Kim, Heejin Jeong, Jun Won Park, Kevin L Winthrop, Eun Bong Lee | |
8. | [Comment] Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling | Laura Boekel | |
9. | [Clinical Picture] Blau syndrome presenting as lipoma arborescens | Hanlin Yin, Wanyi Lin, Langxian Zhi, Fuli Yin, Shaoying Yang, Liangjing Lu | |
10. | [Corrections] Correction to Lancet Rheumatol 2022; 4: e177–87 | | |
11. | [News] CAR T-cell therapy for SLE in children | Talha Burki | |
12. | [Series] Fibrotic phenotype of IgG4-related disease | Marco Lanzillotta, Emma Culver, Amita Sharma, Yoh Zen, Wen Zhang, John H Stone, Emanuel Della-Torre | |
13. | [Series] Large vessel giant cell arteritis | Kornelis S M van der Geest, Maria Sandovici, Thorsten A Bley, James R Stone, Riemer H J A Slart, Elisabeth Brouwer | |
14. | [Series] Proliferative features of IgG4-related disease | Guy Katz, Yasmin Hernandez-Barco, Diego Palumbo, Thomas V Guy, Lingli Dong, Cory A Perugino | |
15. | [Series] Cranial involvement in giant cell arteritis | Philipp Bosch, Georgina Espigol-Frigolé, Maria C Cid, Susan P Mollan, Wolfgang A Schmidt | |
16. | [Viewpoint] How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis? | Freya Luling Feilding, Laura Crosby, Emily Earle, Richard Beesley, Kerry Leslie, Eilean MacDonald, Catherine Wright, Debbie Wilson, Anna Sherriffs, Teresa Duerr, Athimalaipet V Ramanan, CLUSTER Consortium | |
17. | [Clinical Picture] A fluffy white retinal lesion in a woman with spondyloarthritis treated with tofacitinib | Claudia Fabiani, Stefano Gentileschi, Gian Marco Tosi, Luca Cantarini | |
18. | [Clinical Picture] ANCA-associated large and small vessel vasculitis with aorto-pulmonary-renal syndrome | Tajamul H Mir, Parvaiz A Zargar, Bushra Jabeen, Muzamil Latief, Alok Sharma, Nisar A Wani, Syed Mubashir Nissar, Aabid Hussain, Abid Kuchay, Abdul Rasheed Ahangar, Murtaza Rashid Pala, M Omar Parvaiz | |
2024-05-09 | [Articles] Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study | Gonzalo Borrego-Yaniz, Lourdes Ortiz-Fernández, Adela Madrid-Paredes, Martin Kerick, José Hernández-Rodríguez, Sarah L Mackie, Augusto Vaglio, Santos Castañeda, Roser Solans, Jaume Mestre-Torres, Nader Khalidi, Carol A Langford, Steven Ytterberg, Lorenzo | |
2024-05-09 | [Articles] Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial | Carl S Goodyear, Amit Patel, Eleanor Barnes, Michelle Willicombe, Stefan Siebert, Thushan I de Silva, John A Snowden, Sean H Lim, Sarah J Bowden, Lucinda Billingham, Alex Richter, Miles Carroll, Edward J Carr, Rupert Beale, Daniel Rea, Helen Parry, Sarah | |
2024-05-09 | [Comment] Giant cell arteritis: when genomics drives precision medicine | Davide Martorana, Ingeborg M Bajema | |
2024-05-09 | [Comment] Additional SARS-CoV-2 vaccine doses: a little is better than none | Alfred H J Kim | |
2024-05-07 | [Viewpoint] Clinical assessment and management of lumbar spinal stenosis: clinical dilemmas and considerations for surgical referral | David B Anderson, David J Beard, Francois Rannou, David J Hunter, Pradeep Suri, Lingxiao Chen, James M Van Gelder | |
2024-05-07 | [Review] Precision medicine in Sjögren's disease | Saviana Gandolfo, Michele Bombardieri, Jacques-Olivier Pers, Xavier Mariette, Francesco Ciccia | |
2024-05-04 | [Articles] Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial | Jin Kyun Park, Miriam Kim, Ji In Jung, Ju Yeon Kim, Heejin Jeong, Jun Won Park, Kevin L Winthrop, Eun Bong Lee | |
2024-05-04 | [Comment] Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling | Laura Boekel | |
2024-04-26 | [Clinical Picture] Blau syndrome presenting as lipoma arborescens | Hanlin Yin, Wanyi Lin, Langxian Zhi, Fuli Yin, Shaoying Yang, Liangjing Lu | |
2024-04-20 | [Corrections] Correction to Lancet Rheumatol 2022; 4: e177–87 | | |
2024-04-18 | [News] CAR T-cell therapy for SLE in children | Talha Burki | |
2024-04-11 | [Editorial] Vasculitis: the promising road ahead | The Lancet Rheumatology | |
2024-04-05 | [Comment] Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis | Elise van Mulligen | |
2024-04-05 | [Articles] Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority t | Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge C Olsen, Hallvard Fremstad, Cristina Spada, Tor Magne Madland, Christian A Høili, Gunnstein Bakland, Åse Lexberg, Inger Johanne Widding Hansen, Inger Myrnes Hansen, Hilde H | |
2024-04-02 | [Series] Large vessel giant cell arteritis | Kornelis S M van der Geest, Maria Sandovici, Thorsten A Bley, James R Stone, Riemer H J A Slart, Elisabeth Brouwer | |
2024-04-02 | [Series] Fibrotic phenotype of IgG4-related disease | Marco Lanzillotta, Emma Culver, Amita Sharma, Yoh Zen, Wen Zhang, John H Stone, Emanuel Della-Torre | |
2024-04-02 | [Series] Proliferative features of IgG4-related disease | Guy Katz, Yasmin Hernandez-Barco, Diego Palumbo, Thomas V Guy, Lingli Dong, Cory A Perugino | |
2024-04-02 | [Series] Cranial involvement in giant cell arteritis | Philipp Bosch, Georgina Espigol-Frigolé, Maria C Cid, Susan P Mollan, Wolfgang A Schmidt | |
2024-04-02 | [Series] Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis | Sabrina Arnold, A Richard Kitching, Veronique Witko-Sarsat, Thorsten Wiech, Ulrich Specks, Sebastian Klapa, Sara Comdühr, Anja Stähle, Antje Müller, Peter Lamprecht | |
2024-04-02 | [Series] Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis | Samuel D Falde, Lynn A Fussner, Henry D Tazelaar, Erin K O'Brien, Peter Lamprecht, Maximilian F Konig, Ulrich Specks | |
2024-04-02 | [Comment] Celebrating progress in the vasculitides, old and new | John H Stone | |
2024-03-28 | [Articles] Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study | Alwin Sebastian, Kornelis S M van der Geest, Alessandro Tomelleri, Pierluigi Macchioni, Giulia Klinowski, Carlo Salvarani, Diana Prieto-Peña, Edoardo Conticini, Muhammad Khurshid, Lorenzo Dagna, Elisabeth Brouwer, Bhaskar Dasgupta | |
2024-03-28 | [Comment] Improvement of a giant cell arteritis prediction model | Zandra E Walton, Naomi J Patel | |
2024-03-26 | [Viewpoint] How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis? | Freya Luling Feilding, Laura Crosby, Emily Earle, Richard Beesley, Kerry Leslie, Eilean MacDonald, Catherine Wright, Debbie Wilson, Anna Sherriffs, Teresa Duerr, Athimalaipet V Ramanan, CLUSTER Consortium | |
匿名用户只展示最新 100 条榜单历史,更多历史数据请登录后查看,支持时光机按天筛选